---
layout: post
title: "Drugs for Human Use; Drug Efficacy Study Implementation; Potassium Aminobenzoate Oral Preparations; Withdrawal of Hearing Request; Withdrawal of New Drug Application; Final Resolution of Drug Efficacy Study Implementation"
date: 2026-02-05 18:58:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-04971
original_published: 2022-03-09 00:00:00 +0000
significance: 8.00
---

# Drugs for Human Use; Drug Efficacy Study Implementation; Potassium Aminobenzoate Oral Preparations; Withdrawal of Hearing Request; Withdrawal of New Drug Application; Final Resolution of Drug Efficacy Study Implementation

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 09, 2022 00:00 UTC
**Document Number:** 2022-04971

## Summary

The Food and Drug Administration (FDA or Agency) is announcing that all outstanding hearing requests regarding POTABA (potassium aminobenzoate) Tablets, Capsules, Powder, and Envules under Docket No. FDA-1977-N-0015 (formerly 77N-0187) (this Drug Efficacy Study Implementation (DESI) 7663) have been withdrawn. Therefore, as proposed in the notice of opportunity for hearing (NOOH), FDA finds that the products subject to the application identified in this docket, or any identical, related, or similar (IRS) products, have not been shown to be effective for use under the conditions of use prescribed, recommended, or suggested in the labeling, and hereby withdraws approval of the application under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/09/2022-04971/drugs-for-human-use-drug-efficacy-study-implementation-potassium-aminobenzoate-oral-preparations)
- API: https://www.federalregister.gov/api/v1/documents/2022-04971

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
